Loading...
Carboxyl-terminal truncations alter the activity of the human α-galactosidase A.
Fabry disease is an X-linked inborn error of glycolipid metabolism caused by deficiency of the human lysosomal enzyme, α-galactosidase A (αGal), leading to strokes, myocardial infarctions, and terminal renal failure, often leading to death in the fourth or fifth decade of life. The enzyme is respons...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4342250?pdf=render |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|